SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

Myriad continues to develop its Precise MRD assay to meet the needs of patients with cancer, academic partners, and biopharma ...

The findings challenge previous assumptions about butterfly migration and highlight the role of phenotypic plasticity.

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

A national DNA forensics firm is now working to help identify the headless skeleton remains found in Natchez in 2024. The ...

The Dovetail Certified Service Provider program sets stringent standards of proficiency and data quality that service labs ...

This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...

Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products ? the Sequins Metagenomics Core Control and ...

Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products – the Sequins Metagenomics Core Control and ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Request To Download Free Sample of This Strategic Report @ Introduction: The genetic testing market in Vietnam has witnessed significant growth in recent years, fueled by advancements in technology, ...

Madras on Monday launched Bharat cancer genome atlas to boost research and personalise treatment against the deadly disease ...